Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Explore how weekly and monthly automatic buys work for Dividend Aristocrats ETFs and why they can simplify investing. Learn practical steps to set up automatic contributions.
16,823 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A potential federal shift on cannabis could redefine the playing field for Canopy Growth, Tilray, and Green Thumb. Th...
When a board member sells 7,000 shares, traders and long-term investors want to know why. This article breaks down Fo...
As AMD gears up for its July 22 AI event, traders are weighing the risk and reward. This article outlines why the set...
When top stars clash over spotlight, everyday money lessons emerge. Learn how to translate big-budget show dynamics i...
A Michigan father received a frightening call about his son being in jail. He paid $5,500 with gift cards, unaware th...
Tariff news rattled markets, but crypto found footing and moved higher. This piece breaks down the rebound dynamics, ...
Investors flocked to Ferroglobe after a midweek earnings update, turning a measured bounce into a genuine momentum pl...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
Powell Industries stock soars after a significant stake increase by a prominent fund, driving a 161% annual gain. Thi...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...